Search - tctmd.com

Displaying 21 - 40 of 205

Sort: Relevancy | Date

Early, Intense GDMT Improves Decongestion in Acute HF: STRONG-HF

News Daily News

Early, Intense GDMT Improves Decongestion in Acute HF: STRONG-HF

July 19, 2024

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

HF Severity, Outcomes Tied to Markers of Neurodegeneration

News Daily News

HF Severity, Outcomes Tied to Markers of Neurodegeneration

June 04, 2024

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

News Conference News ESC Heart Failure 2024

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

Michael O'Riordan

May 21, 2024

Should Conduction-System Pacing Be Top Choice for CRT?

News Conference News EHRA 2024

Should Conduction-System Pacing Be Top Choice for CRT?

April 15, 2024

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

Presentation ACC 2024

A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy

Presenter: James L. Januzzi Jr

April 08, 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

April 06, 2024

Physicians (Mostly) Negative on Private Equity in Healthcare

News Daily News

Physicians (Mostly) Negative on Private Equity in Healthcare

Michael O'Riordan

March 13, 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

AL Cardaic Amyloidosis: A Primer for the Nonhematologist

Presentation THT 2024

AL Cardaic Amyloidosis: A Primer for the Nonhematologist

Presenter: Jan Griffin

March 05, 2024

Cardiac Recovery in Response to Temporary Mechanical Circulatory Support

Presentation THT 2024

Cardiac Recovery in Response to Temporary Mechanical Circulatory Support

Presenter: Jane E. Wilcox

March 04, 2024

TCTMD’s Top 10 Most Popular Stories for January 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2024

February 01, 2024

GDMT Rates Low in HFrEF, Particularly in Women

News Daily News

GDMT Rates Low in HFrEF, Particularly in Women

January 30, 2024

CRT-D Offers Persistent Survival Benefit in Long-term RAFT Results

News Daily News

CRT-D Offers Persistent Survival Benefit in Long-term RAFT Results

January 23, 2024

HeartMate 3 Use Postapproval Is Soaring—and Equitably, New Numbers Show

News Daily News

HeartMate 3 Use Postapproval Is Soaring—and Equitably, New Numbers Show

Yael L. Maxwell

January 10, 2024

COVID-Related Decline in Acute CV Hospitalizations Sustained Through 2021

News Daily News

COVID-Related Decline in Acute CV Hospitalizations Sustained Through 2021

January 09, 2024

January 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

January 01, 2024

What’s Going to Be Hot at AHA 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

November 07, 2023

TCT 371: C-reactive protein apheresis in cardiogenic shock – case series from the C-reactive protein apheresis in the Acute Myocardial Infarction-Registry (CAMI-R)

Presentation TCT 2023

TCT 371: C-reactive protein apheresis in cardiogenic shock – case series from the C-reactive protein apheresis in the Acute Myocardial Infarction-Registry (CAMI-R)

Presenter: Jan Torzewski

October 25, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.